Document ID: chunk:federal_register_of_legislation:F2022C01116:clause:1_1:p2
Version: federal_register_of_legislation:F2022C01116
Segment Type: clause
Provision Reference: sch 1 cl 1 (pt 2/2)
Character Range: 10798–13343

= disallowed by Parliament           reloc = relocated
Div = Division(s)                               renum = renumbered
exp = expires/expired or ceases/ceased to have  rep = repealed
effect                                          rs = repealed and substituted
F = Federal Register of Legislation             s = section(s)/subsection(s)
gaz = gazette                                   Sch = Schedule(s)
LA = Legislation Act 2003                       Sdiv = Subdivision(s)
LIA = Legislative Instruments Act 2003          SLI = Select Legislative Instrument
(md not incorp) = misdescribed amendment        SR = Statutory Rules
cannot be given effect                          Sub‑Ch = Sub‑Chapter(s)
mod = modified/modification                     SubPt = Subpart(s)
No. = Number(s)                                 underlining = whole or part not
o = order(s)                                    commenced or to be commenced
Ord = Ordinance

Endnote 3—Legislation history

Name                                                                                                                                              Registration   Commencement  Application, saving and transitional provisions
Therapeutic Goods (Medical Devices—Excluded Purposes) Specification 2020                                                                          9 Sep 2020     1 Oct 2020    —
                                                                                                                                                  (F2020L01150)
Therapeutic Goods (Medical Devices—Excluded Purposes) Amendment (COVID-19 Rapid Antigen IVD Medical Devices for Self-Testing) Specification 2021  29 Sep 2021    1 Oct 2021    —
                                                                                                                                                  (F2021L01347)
Therapeutic Goods (Medical Devices—Excluded Purposes) Amendment (COVID-19 Self-Testing) Specification 2022                                        27 Oct 2022    28 Oct 2022   —
                                                                                                                                                  (F2022L01403)

Endnote 4—Amendment history
Provision affected          How affected
s 2.....................    rep LA s 48D
s 4.....................    am F2021L01347
s 4A....................    ad F2021L01347
s 7.....................    rep LA s 48C
Schedule 1................  am F2021L01347; F2022L01403
Schedule 2................  rep LA s 48C